文献速递消化内镜消化道肿瘤与早癌

广野内镜黏膜切除术与内镜黏膜下剥离术治疗侧向发育型结直肠病变的成本效果分析

Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis.
PubMed 文献 · Gut · 2017-10-07

本研究采用决策树模型进行增量成本效果分析,比较广野内镜黏膜切除术(WF-EMR)、全部内镜黏膜下剥离术(U-ESD)和选择性ESD(S-ESD)治疗>20 mm的大无蒂和侧向发育型结直肠病变的成本效果。S-ESD是最便宜且更有效的策略,每1000例可避免19例额外手术;U-ESD相比S-ESD每避免1例手术的增量成本为210 112美元,仅在高风险直肠病变中具有成本效果。

要点

  • S-ESD是首选治疗策略,每1000例侧向发育型结直肠病变仅需43例ESD。
  • U-ESD相比S-ESD每避免1例手术的增量成本为210 112美元,仅在高风险直肠病变中具有成本效果。
  • 对于大多数侧向发育型结直肠病变,WF-EMR仍是有效且安全的治疗选择。

核心结论

  • S-ESD是首选治疗策略,U-ESD仅在高风险直肠病变中具有成本效果,WF-EMR对大多数侧向发育型结直肠病变仍是有效且安全的治疗选择。

研究设计与样本

  • 采用决策树模型进行增量成本效果分析,时间跨度18个月,比较WF-EMR、U-ESD和S-ESD三种策略,数据来源于大型西方队列和文献。
  • 共分析1765例患者的1723个病变,效果定义为每1000例中避免的手术例数,并计算每避免1例手术的增量成本。

主要发现

  • 黏膜下浸润癌(SMIC)和低风险SMIC的患病率分别为8.2%和3.1%。
  • 内镜评估SMIC的灵敏度和特异度分别为34.9%和98.4%。
  • S-ESD是最便宜的策略,且相比WF-EMR每1000例可避免19例额外手术。
  • U-ESD相比S-ESD每1000例可再避免13例手术,每避免1例手术的增量成本为210 112美元。
  • U-ESD仅在高风险直肠病变中具有成本效果。

关键数值与推荐

  • S-ESD策略下每1000例侧向发育型结直肠病变需要43例ESD操作。
  • SMIC患病率为8.2%,低风险SMIC患病率为3.1%。
  • 内镜评估SMIC的灵敏度为34.9%,特异度为98.4%。
  • U-ESD相比S-ESD每避免1例手术的增量成本为210 112美元。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the cost-effectiveness of endoscopic submucosal dissection (ESD) and wide-field endoscopic mucosal resection (WF-EMR) for removing large sessile and laterally spreading colorectal lesions (LSLs) >20 mm. DESIGN: An incremental cost-effectiveness analysis using a decision tree model was performed over an 18-month time horizon. The following strategies were compared: WF-EMR, universal ESD (U-ESD) and selective ESD (S-ESD) for lesions highly suspicious for containing submucosal invasive cancer (SMIC), with WF-EMR used for the remainder. Data from a large Western cohort and the literature were used to inform the model. Effectiveness was defined as the number of surgeries avoided per 1000 cases. Incremental costs per surgery avoided are presented. Sensitivity and scenario analyses were performed. RESULTS: 1723 lesions among 1765 patients were analysed. The prevalence of SMIC and low-risk-SMIC was 8.2% and 3.1%, respectively. Endoscopic lesion assessment for SMIC had a sensitivity and specificity of 34.9% and 98.4%, respectively. S-ESD was the least expensive strategy and was also more effective than WF-EMR by preventing 19 additional surgeries per 1000 cases. 43 ESD procedures would be required in an S-ESD strategy. U-ESD would prevent another 13 surgeries compared with S-ESD, at an incremental cost per surgery avoided of US$210 112. U-ESD was only cost-effective among higher risk rectal lesions. CONCLUSION: S-ESD is the preferred treatment strategy. However, only 43 ESDs are required per 1000 LSLs. U-ESD cannot be justified beyond high-risk rectal lesions. WF-EMR remains an effective and safe treatment option for most LSLs. TRIAL REGISTRATION NUMBER: NCT02000141.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Bahin FF, Heitman SJ, Rasouli KN, et al. Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis. Gut. 2017. PMID: 28988198. doi:10.1136/gutjnl-2017-313823

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。